Booster doses of current Covid-19 vaccines may not be enough: WHO

The WHO has said that current Covid-19 vaccines may need to be updated if they are to provide continued protection against emerging variants, including Omicron

Covid vaccine booster, j&j
Covid vaccine booster
IANS Geneva
1 min read Last Updated : Jan 12 2022 | 7:09 AM IST

The World Health Organisation (WHO) has said that current Covid-19 vaccines may need to be updated if they are to provide continued protection against emerging variants, including Omicron.

WHO's Technical Advisory Group on Covid-19 Vaccine Composition (TAG-CO-VAC), a group of 18 experts, on Tuesday said that although current vaccines provide a high level of protection against severe disease and death caused by Variants Of Concern (VOC), future vaccines that can prevent infection and transmission need to be developed.

In the meantime, the composition of current Covid-19 vaccines may need to be updated in order to protect against the evolution of the virus, Xinhua news agency reported.

Such updates need to be based on strains that are genetically and antigenically close to the circulating variants. They should also elicit "broad, strong, and long-lasting" responses in order to "reduce the need for successive booster doses," WHO added.

The experts have encouraged Covid-19 vaccine manufacturers to provide data on the performance of current and Omicron-specific vaccines, to help decide when changes to vaccine composition may be required.

Regarding the current Omicron variant, the experts emphasised the importance of wider global access to current Covid-19 vaccines.

--IANS

int/khz/

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusOmicronCoronavirus VaccineWHO

First Published: Jan 12 2022 | 7:09 AM IST

Next Story